These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7044304)

  • 41. Cloning and molecular epidemiology of plasmid-determined fosfomycin resistance.
    Villar CJ; Hardisson C; Suárez JE
    Antimicrob Agents Chemother; 1986 Feb; 29(2):309-14. PubMed ID: 3521477
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction of fosfomycin with the glycerol 3-phosphate transporter of Escherichia coli.
    Santoro A; Cappello AR; Madeo M; Martello E; Iacopetta D; Dolce V
    Biochim Biophys Acta; 2011 Dec; 1810(12):1323-9. PubMed ID: 21791237
    [TBL] [Abstract][Full Text] [Related]  

  • 43. fosI Is a New Integron-Associated Gene Cassette Encoding Reduced Susceptibility to Fosfomycin.
    Pelegrino Kde O; Campos JC; Sampaio SC; Lezirovitz K; Seco BM; Pereira Mde O; Rocha DA; Jové T; Nicodemo AC; Sampaio JL
    Antimicrob Agents Chemother; 2016 Jan; 60(1):686-8. PubMed ID: 26552984
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Periplasmic protein related to the sn-glycerol-3-phosphate transport system of Escherichia coli.
    Silhavy TJ; Hartig-Beecken I; Boos W
    J Bacteriol; 1976 May; 126(2):951-8. PubMed ID: 770459
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structure and Dynamics of FosA-Mediated Fosfomycin Resistance in Klebsiella pneumoniae and Escherichia coli.
    Klontz EH; Tomich AD; Günther S; Lemkul JA; Deredge D; Silverstein Z; Shaw JF; McElheny C; Doi Y; Wintrode PL; MacKerell AD; Sluis-Cremer N; Sundberg EJ
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874374
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
    Oteo J; Orden B; Bautista V; Cuevas O; Arroyo M; Martínez-Ruiz R; Pérez-Vázquez M; Alcaraz M; García-Cobos S; Campos J
    J Antimicrob Chemother; 2009 Oct; 64(4):712-7. PubMed ID: 19671590
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Two kinds of mutants defective in multiple carbohydrate utilization isolated from in vitro fosfomycin-resistant strains of Escherichia coli K--12.
    Tsuruoka T; Miyata A; Yamada Y
    J Antibiot (Tokyo); 1978 Mar; 31(3):192-201. PubMed ID: 206529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Experiences in fosfomycin susceptibility testing and resistance mechanism determination in Escherichia coli from urinary tract infections in the UK.
    Cottell JL; Webber MA
    J Med Microbiol; 2019 Feb; 68(2):161-168. PubMed ID: 30543320
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasmids of Diverse Inc Groups Disseminate the Fosfomycin Resistance Gene
    Wang XM; Dong Z; Schwarz S; Zhu Y; Hua X; Zhang Y; Liu S; Zhang WJ
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of a Cys115 to Asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin.
    Kim DH; Lees WJ; Kempsell KE; Lane WS; Duncan K; Walsh CT
    Biochemistry; 1996 Apr; 35(15):4923-8. PubMed ID: 8664284
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A genome-wide analysis of Escherichia coli responses to fosfomycin using TraDIS-Xpress reveals novel roles for phosphonate degradation and phosphate transport systems.
    Turner AK; Yasir M; Bastkowski S; Telatin A; Page AJ; Charles IG; Webber MA
    J Antimicrob Chemother; 2020 Nov; 75(11):3144-3151. PubMed ID: 32756955
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasmid-mediated fosfomycin resistance in Escherichia coli isolated from pig.
    Ho PL; Chan J; Lo WU; Law PY; Chow KH
    Vet Microbiol; 2013 Mar; 162(2-4):964-967. PubMed ID: 23078751
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of the CpxAR two-component signal transduction system in control of fosfomycin resistance and carbon substrate uptake.
    Kurabayashi K; Hirakawa Y; Tanimoto K; Tomita H; Hirakawa H
    J Bacteriol; 2014 Jan; 196(2):248-56. PubMed ID: 24163343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Mechanism of fosfomycin-resistance in clinical isolates].
    O'Hara K; Hashimoto H
    Jpn J Antibiot; 1996 Jun; 49(6):533-43. PubMed ID: 8776629
    [No Abstract]   [Full Text] [Related]  

  • 55. Urinary Tract Conditions Affect Fosfomycin Activity against Escherichia coli Strains Harboring Chromosomal Mutations Involved in Fosfomycin Uptake.
    Martín-Gutiérrez G; Docobo-Pérez F; Rodriguez-Beltrán J; Rodríguez-Martínez JM; Aznar J; Pascual A; Blázquez J
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038268
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biological cost of fosfomycin resistance in Escherichia coli in a murine model of urinary tract infection.
    Pourbaix A; Guérin F; Lastours V; Chau F; Auzou M; Boulley E; Cattoir V; Fantin B
    Int J Med Microbiol; 2017 Dec; 307(8):452-459. PubMed ID: 28986014
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of fosfomycin resistance among ESBL-producing Escherichia coli isolates in the community, Switzerland.
    Mueller L; Cimen C; Poirel L; Descombes MC; Nordmann P
    Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):945-949. PubMed ID: 30877486
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tet38 Efflux Pump Contributes to Fosfomycin Resistance in Staphylococcus aureus.
    Truong-Bolduc QC; Wang Y; Hooper DC
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891612
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Susceptibility to fosfomycin of hospital strains isolated in Nantes (France). Frequency of mutation to resistance.
    Courtieu AL; Drugeon H; Billaudel S
    Chemotherapy; 1977; 23 Suppl 1():25-36. PubMed ID: 401717
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Validation of the mutant selection window hypothesis with fosfomycin against Escherichia coli and Pseudomonas aeruginosa: an in vitro and in vivo comparative study.
    Pan AJ; Mei Q; Ye Y; Li HR; Liu B; Li JB
    J Antibiot (Tokyo); 2017 Feb; 70(2):166-173. PubMed ID: 27756910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.